Angeion Corporation (Angeion), incorporated in May 1986, is engaged in developing, manufacturing and selling medical products. Through the Company's Medical Graphics Corporation subsidiary, Angeion designs and markets non-invasive cardiorespiratory diagnostic systems that are sold under the MedGraphics and New Leaf brand and trade names. These cardiorespiratory diagnostic systems have a range of applications in healthcare, wellness, and health and fitness. Through rapid analysis of an individual's inhaled and exhaled
breath, Angeion's advanced technologies provide physicians, health
professionals, trainers and coaches with a non-invasive diagnostic
window to view a person's overall cardiorespiratory health and
fitness.
Primary MedGraphics brand products include pulmonary function (PFT) and cardiopulmonary gas exchange (GX) testing systems. All MedGraphics' products, except for certain original equipment manufacturer (OEM) products, are sold with a personal computer, full color monitor, printer and other peripherals. The Company also sells one of its cardiorespiratory diagnostic systems together with other consumable products under the New Leaf brand to consumers through health and fitness clubs, personal training studios, weight loss centers and other retail outlets. The Company sells its cardiorespiratory diagnostic systems and services to clinical research customers for use in conducting safety and efficacy clinical trial studies both in the United States and internationally.
The clinical importance ranges from prevention to early detection
and effective management of a wide range of cardiopulmonary diseases
such as asthma, emphysema and congestive heart failure. In the
health and fitness arena, Angeion's health management solutions
help individuals achieve weight management, cardiovascular fitness,
and athletic performance goals through precise measurement of metabolism
at rest and during exercise.
